BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6402385)

  • 1. The morning after: novel hormonal approaches to postcoital interception.
    Adashi EY
    Fertil Steril; 1983 Mar; 39(3):267-9. PubMed ID: 6402385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-coital contraception].
    Serfaty D
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency contraception: a review.
    Haspels AA
    Contraception; 1994 Aug; 50(2):101-8. PubMed ID: 7956209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women.
    Van Santen MR; Haspels AA
    Fertil Steril; 1985 Feb; 43(2):206-13. PubMed ID: 3881294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA; Smith RP; Rademaker AW
    Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
    Ling WY; Wrixon W; Acorn T; Wilson E; Collins J
    Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ovulatory contraception.
    Glasier A; Baird DT
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):283-91. PubMed ID: 2225600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol.
    Kubba AA; White JO; Guillebaud J; Elder MG
    Fertil Steril; 1986 Apr; 45(4):512-6. PubMed ID: 3956767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
    Webb AM; Russell J; Elstein M
    BMJ; 1992 Oct; 305(6859):927-31. PubMed ID: 1458074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens.
    Zuliani G; Colombo UF; Molla R
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):253-60. PubMed ID: 2227068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
    Johansson ED; Elamsson K; Elmestedt U
    Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of estrogens as postcoital contraceptive agents. Clinical effectiveness and potential mode of action.
    Blye RP
    Am J Obstet Gynecol; 1973 Aug; 116(7):1044-50. PubMed ID: 4577932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phasic approach to oral contraceptives.
    Hale RW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postcoital contraception: present and future options.
    Derman SG; Peralta LM
    J Adolesc Health; 1995 Jan; 16(1):6-11. PubMed ID: 7742340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraception after unprotected sex.
    Blaney CL
    Netw Res Triangle Park N C; 1994 Dec; 15(2):4-8. PubMed ID: 12319047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.